Full year results from a specialist engineering group covered here offer encouragement, but can it keep it going? Elsewhere in the world of engineering services, one of AIM’s larger companies is as steady as ever, with a huge order book offering plenty of visibility. Read on here for our thoughts on this and other news. (Premium)
Accrol: bog all to like?
Accrol (AIM: ACRL), a leading independent tissue converter (think toilet rolls), reported in-line results for the six months ending 31 October 2023.
Revenue fell 17.2% to £100.3m due to the easing of prices offered to customers following significant inflationary pressures in the prior year.
Gross profit of £27.4m and the modest gross profit margin of 27.3% highlights the margin risk of this sort of business when faced…
Access the all latest company comments on Investor's Champion.
Not yet registered? It's free to register. Register now.
Register on Investor's Champion
Access the all latest company comments on Investor's Champion.
Premium Content
Premium content provides more in-depth information on fascinating investment stories and research to help make your money go further.
Access Premium Content through individual credits (we only want you to read what you are interested in) or through an annual subscription, which works out as only 25p per day – a small price to guide you through the investing maze!
Subscription
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
In depth coverage of many of the world’s great companies
Breaking news on potential upcoming disasters
Unique insights from our top research team
Credits
Get access to our premium content for as little as £3.20 per article.
